Study on the Safety and Tolerability of ODM-212 for Patients with Advanced Solid Tumors
- Substances:Odm-212
Finland- Participants:18–64 years · 65+ years
- Substances:Odm-212
- Sponsor:Orion Corporation
Rare diseases
Investigational molecules
Locations
Back to Finland297 clinical trials in Turku, Finland across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Finland
Finland
Finland
Finland
Finland
Finland
Finland
Finland
Finland
Finland
Finland
FinlandThe busiest research cities in the country
What the registry says about research in the country
Comprehensive research focusing on respiratory infections including trials for influenza, RSV, and human metapneumovirus vaccines. Studies evaluate preventive measures for vulnerable populations.
Multiple trials aim to enhance protection against seasonal respiratory illnesses in different age groups.
Research centered on preventing and treating various infectious conditions, including studies of meningococcal vaccines and innovative approaches to viral infections.
Studies focus on developing effective vaccination strategies for different age groups and populations.
Innovative trials examining treatments for obesity and diabetes, with particular attention to weight management therapies and metabolic health improvements.
Research emphasizes lifestyle modifications alongside medical interventions.
Advanced research in cancer treatment, particularly focusing on breast cancer and innovative therapeutic combinations for improved patient outcomes.
Studies evaluate both targeted therapies and combination treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.